A Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
CME/MOC, NCPD and ACPE Accredited
Program Schedule — Eastern Time
Saturday, October 17, 2026
6:45 AM – 7:15 AM — Registration
7:15 AM – 12:00 PM — Educational Meeting
Location
The Ritz-Carlton Orlando Grande Lakes
4012 Central Florida Parkway
Orlando, Florida Hotel
Phone: (407) 206-2400
Meeting Room
To be announced.
No registration fee. Preregistration is required for in-person attendance in Orlando as seating is limited. See the Location tab below for hotel booking instructions.
Breast Cancer
To be announced.
Prostate Cancer
To be announced.
Relapsed/Refractory Multiple Myeloma
Faculty
Paul G Richardson
MD
Dana-Farber Cancer Institute, Boston, Massachusetts
Clinical Program Leader and Director of Clinical Research, Jerome Lipper Multiple Myeloma Center
Harvard Medical School, Boston, Massachusetts
RJ Corman Professor of Medicine
Moderator
Neil Love
MD
Research To Practice
Miami, Florida
Additional faculty to be announced.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Gilead Sciences Inc, and Puma Biotechnology Inc.
Join us on Saturday, October 17th from 7:15 AM to 12:00 PM eastern time.
7:15 AM – 7:25 AM – Welcome, Introductions and Meeting Overview
7:25 AM – 9:40 AM – MODULE 1: Breast Cancer
Localized Hormone Receptor (HR)-Positive Breast Cancer; Initial Therapy for Metastatic Disease
HER2-Positive Breast Cancer
Relapsed/Refractory HR-Positive Metastatic Breast Cancer
Triple-Negative Breast Cancer
9:40 AM – 10:00 AM – BREAK
10:00 AM – 11:00 AM – MODULE 2: Prostate Cancer
Hormonal Therapy for Prostate Cancer
Other Therapeutic Strategies
11:00 AM – 12:00 PM – MODULE 3: Relapsed/Refractory Multiple Myeloma
Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for R/R Multiple Myeloma
Other Therapeutic Strategies
12:00 PM – Meeting Adjourns
Target Audience
This activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, surgeons, radiation oncologists, pharmacists, nurse practitioners, clinical nurse specialists and other healthcare professionals involved in the treatment of cancer.
Learning Objectives
To be announced.
CE Credit
CME, ABIM MOC, ABS and ACPE credit information will be given to each participant as part of the meeting course materials.
NCPD Credit
To obtain a certificate of completion and receive credit for this event, nurses must attend the entire activity and return a completed Educational Assessment and Credit Form. A credit form link will be given to each participant as part of the meeting course materials.
CME Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation Statement
Research To Practice designates this live activity for a maximum of [TBD] AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine (ABIM) — Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component and a post-test, enables the participant to earn up to [TBD] Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please note, this program has been specifically designed for the following ABIM specialty: medical oncology.
American Board of Surgery (ABS) — Continuous Certification (CC)
Successful completion of this CME activity, which includes participation in the evaluation component and a post-test, enables the learner to earn up to [TBD] Medical Knowledge MOC points toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABS credit.
Please note, this program has been specifically designed for the following ABS practice area: complex general surgical oncology.
NCPD Accreditation Statement
Research To Practice is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
NCPD Credit Designation Statement
This educational activity for [TBD] contact hours is provided by Research To Practice.
This activity is awarded [TBD] ANCC pharmacotherapeutic contact hours.
ONCC/Individual Learning Needs Assessment (ILNA) Certification Information
This activity will be remitted for ONCC/ILNA approval.
ACPE Accreditation Statement
The University of Texas at Austin College of Pharmacy Continuing Professional Development provided the ACPE accreditation for this course. The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
ACPE Credit Designation Statement
This activity is approved for up to [TBD] CEU ([TBD] contact hours) of continuing education credit. To receive [TBD] contact hours of CE credit, the participant must attend each session and complete the online evaluation. Upon successful completion of the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3 to 4 weeks for processing).
Privacy Policy
Personal information and data sharing: Research To Practice aggregates deidentified user data for program-use analysis, program development, activity planning and site improvement. We may provide aggregate and deidentified data to third parties, including commercial supporters. We do not share or sell personally identifiable information to any unaffiliated third parties or commercial supporters. Please see our privacy policy at ResearchToPractice.com/Privacy-Policy for more information.
Unlabeled/Unapproved Uses Notice
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the provider or grantors.
Content Validation and Disclosures
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education and adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited continuing education activity, including faculty, planners, reviewers and others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships will have been mitigated prior to the commencement of this activity. In addition, all activity content is reviewed by RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
FACULTY
To be announced.
MODERATOR
Dr Love is president and CEO of Research To Practice. Research To Practice receives funds in the form of educational grants to develop CME activities from the following companies: Aadi Bioscience, AbbVie Inc, ADC Therapeutics, Agendia Inc, Alexion Pharmaceuticals, Amgen Inc, Array BioPharma Inc, a subsidiary of Pfizer Inc, Arvinas, Astellas, AstraZeneca Pharmaceuticals LP, Aveo Pharmaceuticals, Bayer HealthCare Pharmaceuticals, BeOne, Biotheranostics Inc, A Hologic Company, Black Diamond Therapeutics Inc, Blueprint Medicines, Boehringer Ingelheim Pharmaceuticals Inc, Bristol Myers Squibb, Catalyst Pharmaceuticals Inc, Celcuity, Clovis Oncology, Coherus BioSciences, Corcept Therapeutics Inc, CTI BioPharma, a Sobi Company, Daiichi Sankyo Inc, Eisai Inc, Elevation Oncology Inc, Exact Sciences Corporation, Exelixis Inc, Genentech, a member of the Roche Group, Genmab US Inc, Geron Corporation, Gilead Sciences Inc, GSK, Helsinn Therapeutics (US) Inc, ImmunoGen Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Jazz Pharmaceuticals Inc, Johnson & Johnson, Karyopharm Therapeutics, Kite, A Gilead Company, Kura Oncology, Legend Biotech, Lilly, MEI Pharma Inc, Merck, Mersana Therapeutics Inc, Mirati Therapeutics Inc, Mural Oncology Inc, Natera Inc, Novartis, Novartis Pharmaceuticals Corporation on behalf of Advanced Accelerator Applications, Novocure Inc, Nuvalent, Nuvation Bio Inc, Pfizer Inc, Pharmacyclics LLC, an AbbVie Company, Puma Biotechnology Inc, Regeneron Pharmaceuticals Inc, Revolution Medicines Inc, Rigel Pharmaceuticals Inc, R-Pharm US, Sanofi, Seagen Inc, Servier Pharmaceuticals LLC, SpringWorks Therapeutics Inc, Stemline Therapeutics Inc, Sumitomo Pharma America, Summit Therapeutics, Syndax Pharmaceuticals, Taiho Oncology Inc, Takeda Pharmaceuticals USA Inc, TerSera Therapeutics LLC, Tesaro, A GSK Company, and Verastem Inc.
Research To Practice CME/NCPD/ACPE Planning Committee Members, Staff and Reviewers
Planners, scientific staff and independent reviewers for Research To Practice have no relevant financial relationships to disclose.
Supporters
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Gilead Sciences Inc, and Puma Biotechnology Inc.
The Ritz-Carlton Orlando Grande Lakes
4012 Central Florida Parkway
Orlando, FL 32837
Hotel Phone: (407) 206-2400
Meeting Room
To be announced.
Hotel Room Reservations
- Florida Cancer Specialists (FCS) members, please be sure to book accommodations in the FCS room block.
- For all other registrants, room reservation information will be included with the confirmation email after you have registered for this program.
Program slides will be made available prior to the start of the session.
Registration to attend virtually is open to all professionals.
Please click the link to register for this live event directly on Zoom. Once you register, Zoom will send a confirmation email with your individual link to access the event. Please keep that confirmation email handy. If you do not receive it, contact our support team at meetings@researchtopractice.com.
This activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, surgeons, radiation oncologists, pharmacists, nurse practitioners, clinical nurse specialists and other healthcare professionals involved in the treatment of cancer.
At this time, in-person registration for this educational activity is limited to practicing clinicians. For all other professionals,* we are unable to confirm seating at this time. To request placement on the standby list for available seating, please email Meetings@ResearchToPractice.com.
No registration fee is charged for this event. Preregistration is required as seating is limited.
* Individuals employed by for-profit organizations, including financial institutions and biotech or pharmaceutical companies.
To ensure seating and meal service, please check in at our onsite registration desk before the start of the meeting. We cannot guarantee seating after the start of the program.
Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings.
Research To Practice fully complies with the legal requirements of the ADA. If you require any physical, dietary or other accommodations, please call us at (800) 233-6153 before the event.
If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153.